Honeywell disappoints on quarterly results — but delivers on its breakup plan

Honeywell posted Q1 adjusted EPS of $2.45, above the $2.32 estimate, but revenue of $9.1 billion missed the $9.3 billion consensus and the stock fell about 3% intraday. Management kept full-year 2026 guidance mostly unchanged while issuing Q2 sales guidance of $9.4 billion to $9.6 billion versus $9.73 billion expected, citing war-related disruptions and supply chain headwinds. The bigger strategic update was progress on the breakup plan, including the sale of Workflow Solutions and a June 29 Aerospace spin-off date pending approval.

Analysis

The setup is less about a bad print and more about a forced re-rating event in slow motion. A cleaner industrial structure typically compresses the gap between intrinsic value and market price because each residual business can be valued off its own cycle, margin profile, and terminal growth, which matters here given the market’s current tendency to punish “good but complicated” stories. The near-term weakness is likely to persist until the separation dates are closer, but that weakness is exactly what creates an entry window if the market is over-discounting execution risk.

Second-order, the aerospace spin looks like the highest-quality asset being unlocked into a supply-chain recovery inflection. If output really improves into the next few quarters, backlog conversion plus pricing power can expand the pure-play multiple faster than sell-side models imply, especially because defense and aftermarket revenue usually carry better visibility than headline organic growth suggests. The remaining automation company should also screen better to quality growth investors once the aerospace cyclicality is removed, which can create two separate buyer bases instead of one constrained conglomerate holder base.

The main risk is that the breakup premium gets delayed, not destroyed: any slip in approvals, tax structuring, or execution could push the valuation catalyst out by months, while macro and geopolitics can keep depressing the process segment in the interim. Another risk is that investors anchor on the guided quarter rather than the path to normalization; if supply issues fade slower than expected or inflation re-accelerates, the stock can underperform until the market sees clean evidence of margin durability. In that case, the thesis is still intact, but the mark-to-market could stay noisy for 1-2 quarters.

Consensus appears to be missing that this is effectively a two-step revaluation: first the conglomerate discount unwinds, then each asset can trade on a more appropriate earnings power multiple. That means the upside is probably not linear with quarterly EPS beats; the real catalyst is that the market starts valuing the post-breakup businesses as distinct compounders rather than applying a blended industrial discount. On balance, the selloff looks more like a timing opportunity than a fundamental break.

Key Decisions for Investors

• Add to HON on weakness over the next 1-3 weeks, using the post-earnings dip as entry; target a 12-18 month re-rating as breakup milestones de-risk, with downside limited if the separation remains on schedule.
• Buy HON calls or call spreads dated 6-9 months out to express the breakup premium with defined risk; best risk/reward if implied volatility is still elevated from the disappointment.
• Pair trade: long HON / short a basket of more mature conglomerate-style industrials over 3-6 months; the catalyst is company-specific simplification, not broad beta.
• For event-driven accounts, size a tactical long into the aerospace spin approval window; if the June separation is confirmed, expect multiple expansion in the pure-play aerospace asset over the following 1-2 quarters.
• Avoid chasing the bounce in the first 48-72 hours; wait for the market to digest guidance and for analyst model cuts, then scale in as estimates reset and breakup optionality becomes more investable.